Alternative splicing generates different parkin protein isoforms: Evidences in human, rat, and mouse brain

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Scuderi, Soraya ^a   La Cognata, Valentina ^b   Drago, Filippo ^a   Cavallaro, Sebastiano ^b   D'Agata, Velia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; PARKIN; PARKINSON PROTEIN 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UBIQUITIN PROTEIN LIGASE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; BRAIN; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; ELECTROPHORETIC MOBILITY; EXON; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; MOUSE; NONHUMAN; PARKINSON DISEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; REVIEW; TISSUE DISTRIBUTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; MICE; MUTATION; PARKINSON DISEASE; PROTEIN ISOFORMS; RATS; UBIQUITIN-PROTEIN LIGASES;

EID: 84925744742     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/690796     Document Type: Review

References (66)

1. V. Bonifati, "Autosomal recessive parkinsonism," Parkinsonism and Related Disorders, Vol. 18, supplement 1, pp. S4-S6, 2012.
2. C. B. Lücking, A. Dürr, V. Bonifati et al., "Association between early-onset Parkinson's disease and mutations in the parkin gene," The New England Journal of Medicine, Vol. 342, no. 21, pp. 1560-1567, 2000.
3. S. A. Oliveira, W. K. Scott, E. R. Martin et al., "Parkin mutations and susceptibility alleles in late-onset Parkinson's disease," Annals of Neurology, Vol. 53, no. 5, pp. 624-629, 2003.
4. M. P. Burns, L. Zhang, G. W. Rebeck, H. W. Querfurth, and C. E. Moussa, "Parkin promotes intracellular Aβ1-42 clearance," Human Molecular Genetics, Vol. 18, no. 17, pp. 3206-3216, 2009.
5. J. T. Glessner, K. Wang, G. Cai et al., "Autism genome-wide copy number variation reveals ubiquitin and neuronal genes," Nature, Vol. 459, no. 7246, pp. 569-573, 2009.
6. M. E. Witte, J. G. J. M. Bol, W. H. Gerritsen et al., "Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions," Neurobiology of Disease, Vol. 36, no. 3, pp. 445-452, 2009.
7. R. Cesari, E. S. Martin, G. A. Calin et al., "Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27," Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, no. 10, pp. 5956-5961, 2003.
8. S. Veeriah, B. S. Taylor, S. Meng et al., "Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies," Nature Genetics, Vol. 42, no. 1, pp. 77-82, 2010.
9. M. T. Mira, A. Alcaïs, H. van Thuc et al., "Susceptibility to leprosy is associated with PA RK 2 and PAC RG," Nature, Vol. 427, no. 6975, pp. 636-640, 2004.
10. W. Wongseree, A. Assawamakin, T. Piroonratana, S. Sinsomros, C. Limwongse, and N. Chaiyaratana, "Detecting purely epistatic multi-locus interactions by an omnibus permutation test on ensembles of two-locus analyses," BMC Bioinformatics, Vol. 10, article 294, 2009.
11. K. M. Rosen, V. Veereshwarayya, C. E. Moussa et al., "Parkin protects against mitochondrial toxins and β-amyloid accumulation in skeletal muscle cells," The Journal of Biological Chemistry, Vol. 281, no. 18, pp. 12809-12816, 2006.
12. T. Kitada, S. Asakawa, N. Hattori et al., "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism," Nature, Vol. 392, no. 6676, pp. 605-608, 1998.
13. H. Matsumine, M. Saito, S. Shimoda-Matsubayashi et al., "Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27," American Journal of Human Genetics, Vol. 60, no. 3, pp. 588-596, 1997.
14. V. la Cognata, R. Iemmolo, V. D'Agata et al., "Increasing the coding potential of genomes through alternative splicing: the case of PAR K2 gene," Current Genomics: Bentham Science, Vol. 15, no. 3, pp. 203-216, 2014.
15. K. Ikeuchi, H. Marusawa, M. Fujiwara et al., "Attenuation of proteolysis-mediated cyclin E regulation by alternatively spliced Parkin in human colorectal cancers," International Journal of Cancer, Vol. 125, no. 9, pp. 2029-2035, 2009.
16. T. Kitada, S. Asakawa, S. Minoshima, Y. Mizuno, and N. Shimizu, "Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene," Mammalian Genome, Vol. 11, no. 6, pp. 417-421, 2000.
17. K. Beyer, M. Domingo-Sàbat, J. Humbert, C. Carrato, I. Ferrer, and A. Ariza, "Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease," Neurogenetics, Vol. 9, no. 3, pp. 163-172, 2008.
18. J. Humbert, K. Beyer, C. Carrato, J. L. Mate, I. Ferrer, and A. Ariza, "Parkin and synphilin-1 isoform expression changes in Lewy body diseases," Neurobiology of Disease, Vol. 26, no. 3, pp. 681-687, 2007.
19. E. K. Tan, H. Shen, J. M. M. Tan et al., "Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease," Neurogenetics, Vol. 6, no. 4, pp. 179-184, 2005.
20. V. D'agata and S. Cavallaro, "Parkin transcript variants in rat and human brain," Neurochemical Research, Vol. 29, no. 9, pp. 1715-1724, 2004.
21. Y. Sunada, F. Saito, K. Matsumura, and T. Shimizu, "Differential expression of the parkin gene in the human brain and peripheral leukocytes," Neuroscience Letters, Vol. 254, no. 3, pp. 180-182, 1998.
22. H. Shimura, N. Hattori, S. Kubo et al., "Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients," Annals of Neurology, Vol. 45, no. 5, pp. 668-672, 1999.
23. D. P. Huynh, D. R. Scoles, T. H. Ho, M. R. del Bigio, and S. M. Pulst, "Parkin is associated with actin filaments in neuronal and nonneural cells," Annals of Neurology, Vol. 48, no. 5, pp. 737-744, 2000.
24. M. G. Schlossmacher, M. P. Frosch, W. P. Gai et al., "Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies," The American Journal of Pathology, Vol. 160, no. 5, pp. 1655-1667, 2002.
25. Y. Imai, M. Soda, and R. Takahashi, "Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity," Te Journal of Biological Chemistry, Vol. 275, no. 46, pp. 35661-35664, 2000.
26. H. Shimura, N. Hattori, S. Kubo et al., "Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase," Nature Genetics, Vol. 25, no. 3, pp. 302-305, 2000.
27. J. F. Staropoli, C. McDermott, C. Martinat, B. Schulman, E. Demireva, and A. Abeliovich, "Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity," Neuron, Vol. 37, no. 5, pp. 735-749, 2003.
28. K. K. K. Chung, Y. Zhang, K. L. Lim et al., "Parkin ubiquiti-nates the β-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease," Nature Medicine, Vol. 7, no. 10, pp. 1144-1150, 2001.
29. Y. Zhang, J. Gao, K. K. K. Chung, H. Huang, V. L. Dawson, and T. M. Dawson, "Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1," Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, no. 24, pp. 13354-13359, 2000.
30. N. C. Chan, A. M. Salazar, A. H. Pham et al., "Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy," Human Molecular Genetics, Vol. 20, no. 9, pp. 1726-1737, 2011.
31. S. R. Yoshii, C. Kishi, N. Ishihara, and N. Mizushima, "Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane," The Journal of Biological Chemistry, Vol. 286, no. 22, pp. 19630-19640, 2011.
32. M. R. Cookson, "Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways." Cold Spring Harbor Perspectives in Medicine, Vol. 2, no. 9, Article ID a009415, 2012.
33. S. M. Jin and R. J. Youle, "PINK1-and Parkin-mediated mitophagy at a glance," Journal of Cell Science, Vol. 125, part 4, pp. 795-799, 2012.
34. D. Narendra, A. Tanaka, D. Suen, and R. J. Youle, "Parkin is recruited selectively to impaired mitochondria and promotes their autophagy," The Journal of Cell Biology, Vol. 183, no. 5, pp. 795-803, 2008.
35. C. K. Kontos and A. Scorilas, "Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells," Gene, Vol. 505, no. 1, pp. 153-166, 2012.
36. J. M. Horowitz, J. Myers, M. K. Stachowiak, and G. Torres, "Identification and distribution of Parkin in rat brain," NeuroReport, Vol. 10, no. 16, pp. 3393-3397, 1999.
37. V. D'Agata, M. Grimaldi, A. Pascale, and S. Cavallaro, "Regional and cellular expression of the parkin gene in the rat cerebral cortex," European Journal of Neuroscience, Vol. 12, no. 10, pp. 3583-3588, 2000.
38. W. Gu, N. Abbas, M. Z. Lagunes et al., "Cloning of rat parkin cDNA and distribution of parkin in rat brain," Journal of Neurochemistry, Vol. 74, no. 4, pp. 1773-1776, 2000.
39. J. M. Horowitz, V. A. Vernace, J. Myers et al., "Immunodetection of Parkin protein in vertebrate and invertebrate brains: a comparative study using specific antibodies," Journal of Chemical Neuroanatomy, Vol. 21, no. 1, pp. 75-93, 2001.
40. S. I. Kubo, T. Kitami, S. Noda et al., "Parkin is associated with cellular vesicles," Journal of Neurochemistry, Vol. 78, no. 1, pp. 42-54, 2001.
41. C. C. Stichel, M. Augustin, K. Kühn et al., "Parkin expression in the adult mouse brain," European Journal of Neuroscience, Vol. 12, no. 12, pp. 4181-4194, 2000.
42. A. C. Pawlyk, B. I. Giasson, D. M. Sampathu et al., "Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age," The Journal of Biological Chemistry, Vol. 278, no. 48, pp. 48120-48128, 2003.
43. P. Choi, N. Golts, H. Snyder et al., "Co-association of parkin and β-synuclein," Neuro Report, Vol. 12, no. 13, pp. 2839-2843, 2001.
44. Y. Imai, M. Soda, H. Inoue, N. Hattori, Y. Mizuno, and R. Takahashi, "An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin," Cell, Vol. 105, no. 7, pp. 891-902, 2001.
45. M. Zarate-Lagunes, W. Gu, V. Blanchard et al., "Parkin immunoreactivity in the brain of human and non-human primates: An immunohistochemical analysis in normal conditions and in parkinsonian syndromes," The Journal of Comparative Neurology, Vol. 432, no. 2, pp. 184-196, 2001.
46. B. A. van der Reijden, C. A. J. Erpelinck-Verschueren, B. Löwenberg, and J. H. Jansen, "TRIADs: a new class of proteins with a novel cysteine-rich signature," Protein Science, Vol. 8, no. 7, pp. 1557-1561, 1999.
47. M. Kasap, G. Akpinar, A. Sazci, H. A. Idrisoglu, and H. Vahaboʇlu, "Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood," Neuroscience Letters, Vol. 460, no. 3, pp. 196-200, 2009.
48. V. D'Agata, W. Zhao, A. Pascale, O. Zohar, G. Scapagnini, and S. Cavallaro, "Distribution of parkin in the adult rat brain," Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 26, no. 3, pp. 519-527, 2002.
49. J. Esteve-Rudd, L. Campello, M. Herrero, N. Cuenca, and J. Martín-Nieto, "Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system," Brain Research, Vol. 1352, pp. 70-82, 2010.
50. V. D'Agata, W. Zhao, and S. Cavallaro, "Cloning and distribution of the rat parkin mRNA," Molecular Brain Research, Vol. 75, no. 2, pp. 345-349, 2000.
51. S. M. Solano, D. W. Miller, S. J. Augood, A. B. Young, and J. B. Penney Jr., "Expression of alpha-synuclein, parkin, and ubiq-uitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease," Annals of Neurology, Vol. 47, no. 2, pp. 201-210, 2000.
52. M. R. Cookson, P. J. Lockhart, C. McLendon, C. O'Farrell, M. Schlossmacher, and M. J. Farrer, "RING finger 1 mutations in Parkin produce altered localization of the protein," Human Molecular Genetics, Vol. 12, no. 22, pp. 2957-2965, 2003.
53. C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti, "Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity," Human Molecular Genetics, Vol. 15, no. 13, pp. 2059-2075, 2006.
54. S. R. Sriram, X. Li, H. S. Ko et al., "Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin," Human Molecular Genetics, Vol. 14, no. 17, pp. 2571-2586, 2005.
55. F. Darios, O. Corti, C. B. Lücking et al., "Parkin prevents mito-chondrial swelling and cytochrome c release in mitochondria-dependent cell death," Human Molecular Genetics, Vol. 12, no. 5, pp. 517-526, 2003.
56. Y. Kuroda, T. Mitsui, M. Kunishige et al., "Parkin enhances mitochondrial biogenesis in proliferating cells," Human Molecular Genetics, Vol. 15, no. 6, pp. 883-895, 2006.
57. M. Farrer, P. Chan, R. Chen et al., "Lewy bodies and parkinson-ism in families with parkin mutations," Annals of Neurology, Vol. 50, no. 3, pp. 293-300, 2001.
58. R. Hilker, C. Klein, M. Ghaemi et al., "Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene," Annals of Neurology, Vol. 49, no. 3, pp. 367-376, 2001.
59. C. Klein, P. P. Pramstaller, B. Kis et al., "Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype," Annals of Neurology, Vol. 48, no. 1, pp. 65-71, 2000.
60. M. Maruyama, T. Ikeuchi, M. Saito et al., "Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive Juvenile Parkinsonism," Annals of Neurology, Vol. 48, no. 2, pp. 245-250, 2000.
61. A. West, M. Periquet, S. Lincoln et al., "Complex relationship between Parkin mutations and Parkinson disease," American Journal of Medical Genetics-Neuropsychiatric Genetics, Vol. 114, no. 5, pp. 584-591, 2002.
62. C. Shin and J. L. Manley, "Cell signalling and the control of pre-mRNA splicing," Nature Reviews Molecular Cell Biology, Vol. 5, no. 9, pp. 727-738, 2004.
63. Q. Pan, O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe, "Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing," Nature Genetics, Vol. 40, no. 12, pp. 1413-1415, 2008.
64. E. T. Wang, R. Sandberg, S. Luo et al., "Alternative isoform regulation in human tissue transcriptomes," Nature, Vol. 456, no. 7221, pp. 470-476, 2008.
65. G. S. Wang and T. A. Cooper, "Splicing in disease: disruption of the splicing code and the decoding machinery," Nature Reviews Genetics, Vol. 8, no. 10, pp. 749-761, 2007.
66. W. Springer, T. Hoppe, E. Schmidt, and R. Baumeister, "A Caenorhabditis elegans Parkin mutant with altered solubility couples β-synuclein aggregation to proteotoxic stress," Human Molecular Genetics, Vol. 14, no. 22, pp. 3407-3423, 2005.